These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 31707669)
1. Lentiviral Vector Production in Suspension Culture Using Serum-Free Medium for the Transduction of CAR-T Cells. Do Minh A; Tran MY; Kamen AA Methods Mol Biol; 2020; 2086():77-83. PubMed ID: 31707669 [TBL] [Abstract][Full Text] [Related]
2. Optimized Production of Lentiviral Vectors for CAR-T Cell. Moço PD; de Abreu Neto MS; Fantacini DMC; Picanço-Castro V Methods Mol Biol; 2020; 2086():69-76. PubMed ID: 31707668 [TBL] [Abstract][Full Text] [Related]
3. Transition from serum-supplemented monolayer to serum-free suspension lentiviral vector production for generation of chimeric antigen receptor T cells. Tirapelle MC; Oliveira Lomba AL; Silvestre RN; Mizukami A; Covas DT; Picanço-Castro V; Swiech K Cytotherapy; 2022 Aug; 24(8):850-860. PubMed ID: 35643755 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti-Her2 chimeric antigen receptor gene. Yuan W; Chen J; Cao Y; Yang L; Shen L; Bian Q; Bin S; Li P; Cao J; Fang H; Gu H; Li H J Gene Med; 2018 Jul; 20(7-8):e3027. PubMed ID: 29851200 [TBL] [Abstract][Full Text] [Related]
5. Optimizing lentiviral vector formulation conditions for efficient ex vivo transduction of primary human T cells in chimeric antigen receptor T-cell manufacturing. Luostarinen A; Kailaanmäki A; Turkki V; Köylijärvi M; Käyhty P; Leinonen H; Albers-Skirdenko V; Lipponen E; Ylä-Herttuala S; Kaartinen T; Lesch HP; Kekarainen T Cytotherapy; 2024 Sep; 26(9):1084-1094. PubMed ID: 38661611 [TBL] [Abstract][Full Text] [Related]
6. Development of Third-generation Cocal Envelope Producer Cell Lines for Robust Lentiviral Gene Transfer into Hematopoietic Stem Cells and T-cells. Humbert O; Gisch DW; Wohlfahrt ME; Adams AB; Greenberg PD; Schmitt TM; Trobridge GD; Kiem HP Mol Ther; 2016 Aug; 24(7):1237-46. PubMed ID: 27058824 [TBL] [Abstract][Full Text] [Related]
7. Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. Broussau S; Jabbour N; Lachapelle G; Durocher Y; Tom R; Transfiguracion J; Gilbert R; Massie B Mol Ther; 2008 Mar; 16(3):500-7. PubMed ID: 18180776 [TBL] [Abstract][Full Text] [Related]
8. Production of Lentivirus for the Establishment of CAR-T Cells. Lana MG; Strauss BE Methods Mol Biol; 2020; 2086():61-67. PubMed ID: 31707667 [TBL] [Abstract][Full Text] [Related]
9. Generation of stable suspension producer cell lines for serum-free lentivirus production. Klimpel M; Terrao M; Bräuer M; Dersch H; Biserni M; Melo Do Nascimento L; Schwingal S; Vogel JE; Ferlemann C; Brandt T; Lal NI; Bridgeman K; Petzke A; McDwyer E; Lim JL; Oh S; Brumatti G; Garcia Minambres A; Otte E; Noll T; Pirzas V; Laux H Biotechnol J; 2024 May; 19(5):e2400090. PubMed ID: 38719592 [TBL] [Abstract][Full Text] [Related]
10. Generation of CAR-T Cells for Cancer Immunotherapy. Xu Q; Harto H; Berahovich R; Xu S; Zhou H; Golubovskaya V; Wu L Methods Mol Biol; 2019; 1884():349-360. PubMed ID: 30465215 [TBL] [Abstract][Full Text] [Related]
12. Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors. Mo F; Mamonkin M Methods Mol Biol; 2020; 2086():119-130. PubMed ID: 31707671 [TBL] [Abstract][Full Text] [Related]
13. Antibody-Based CAR T Cells Produced by Lentiviral Transduction. Prommersberger S; Hudecek M; Nerreter T Curr Protoc Immunol; 2020 Mar; 128(1):e93. PubMed ID: 32150338 [TBL] [Abstract][Full Text] [Related]
14. Viral Engineering of Chimeric Antigen Receptor Expression on Murine and Human T Lymphocytes. Hammill JA; Afsahi A; Bramson JL; Helsen CW Methods Mol Biol; 2016; 1458():137-57. PubMed ID: 27581020 [TBL] [Abstract][Full Text] [Related]
15. Progress and Perspectives in the Development of Lentiviral Vector Producer Cells. Ferreira MV; Cabral ET; Coroadinha AS Biotechnol J; 2021 Jan; 16(1):e2000017. PubMed ID: 32686901 [TBL] [Abstract][Full Text] [Related]
16. A new approach to CAR T-cell gene engineering and cultivation using piggyBac transposon in the presence of IL-4, IL-7 and IL-21. Ptáčková P; Musil J; Štach M; Lesný P; Němečková Š; Král V; Fábry M; Otáhal P Cytotherapy; 2018 Apr; 20(4):507-520. PubMed ID: 29475789 [TBL] [Abstract][Full Text] [Related]
17. Establishing functional lentiviral vector production in a stirred bioreactor for CAR-T cell therapy. Tang QL; Gu LX; Xu Y; Liao XH; Zhou Y; Zhang TC Bioengineered; 2021 Dec; 12(1):2095-2105. PubMed ID: 34047682 [TBL] [Abstract][Full Text] [Related]
18. Non-industrial production of therapeutic lentiviral vectors: How to provide vectors to academic CAR-T. Keyer V; Syzdykova L; Ingirbay B; Sedova E; Zauatbayeva G; Kulatay T; Shevtsov A; Shustov AV Biotechnol Bioeng; 2024 Oct; 121(10):3252-3268. PubMed ID: 38963234 [TBL] [Abstract][Full Text] [Related]
19. Efficient Pseudotyping of Different Retroviral Vectors Using a Novel, Codon-Optimized Gene for Chimeric GALV Envelope. Mirow M; Schwarze LI; Fehse B; Riecken K Viruses; 2021 Jul; 13(8):. PubMed ID: 34452336 [TBL] [Abstract][Full Text] [Related]
20. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures. Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]